A functional landscape of resistance to MEK1/2 and CDK4/6 inhibition in NRAS mutant melanoma

Combinatorial inhibition of MEK1/2 and CDK4/6 is currently undergoing clinical investigation in NRAS-mutant melanoma. To prospectively map the landscape of resistance to this investigational regimen, we utilized a series of gain- and loss-of-function forward genetic screens to identify modulators of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Res
Hlavní autoři: Hayes, Tikvah K., Luo, Flora, Cohen, Ofir, Goodale, Amy B., Lee, Yenarae, Pantel, Sasha, Bagul, Mukta, Piccioni, Federica, Root, David E., Garraway, Levi A., Meyerson, Matthew, Johannessen, Cory M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227487/
https://ncbi.nlm.nih.gov/pubmed/30819666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-2711
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky